pocketful logo light
pocketful logo light
Concord Biotech Ltd logo

Concord Biotech Ltd

NSE: CONCORDBIO BSE: 543960

1505.70

(3.64%)

Mon, 21 Sept 2026, 04:53 pm

Concord Biotech Share Price Live Chart

1 Day

(3.64%)

No Result Found

Summary

  • Market Cap (in Cr)

    10972.67

  • Net Profit (in Cr)

    371.64

  • P/B

    9.67

  • Sector P/E

    33.76

  • P/E

    47.19

  • EV/EBITDA

    31.89

  • Debt/Equity (Industry)

    0.24

  • Interest Cover (Industry)

    9.79

  • ROCE (Industry)

    14.04

  • RONW (Industry)

    13.17

  • ROE

    22.26

  • ROCE

    29.53

  • Debt/Equity

    0

  • EPS (TTM)

    30.10

  • Dividend Yield

    0.83

  • Book Value

    174.68

  • Interest Cover

    476.53

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters44.0844.0844.0844.0844.08
FII7.807.588.039.119.35
DII9.229.589.558.879.16
Public38.9038.7638.3337.9537.41
Government00000

Read More

Technical Analysis

RSI

64.89

MACD

17.56

50 DMA

1427.41

200 DMA

1268.59

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic1989.701731.101588.601472.5013301213.90955.30
Fibonacci1731.101632.311571.291472.501373.711312.691213.90
Camarilla1517.211493.511469.801472.501422.391398.691374.98

Pivots Level: Classic

R3

+517.20

1989.70

R2

+258.60

1731.10

R1

+116.10

1588.60

1472.50
1472.50
Pivot Point
LTP: 1579.40

S1

-142.50

1330

S2

-258.60

1213.90

S3

-517.20

955.30

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    1491.28

  • 20-EMA

    1478.98

  • 30-EMA

    1464.29

  • 50-EMA

    1429.02

  • 100-EMA

    1365.66

  • 200-EMA

    1358.31

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
29 May 2026board-meetingsAccounts, Final Dividend
11 Feb 2026board-meetingsQuarterly Results
13 Nov 2025board-meetingsQuarterly Results
13 Aug 2025agm
03 Aug 2025dividendFinal Dividend - Rs. - 10.703 Sept 2025
29 May 2025dividend₹10.70 Dividend /Share03 Sept 2025
23 May 2024agm
23 May 2024dividend₹8.75 Dividend /Share22 Jun 2024
22 May 2024dividendDividend - Rs. - 8.7522 Jun 2024
21 May 2024agmAnnual General Meeting23 Jun 2024

Read More

Peer Comparison

Concord Biotech Ltd logo

Concord Biotech Ltd

Cipla Ltd logo

Cipla Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Read More

Concord Biotech Ltd About

Concord Biotech is engaged in research and development manufacturing, marketing and selling of pharmaceutical products. The Company’s API manufacturing facilities are located at Dholka and Limbasi, and its formulations facility at Valthera in the state of Gujarat, India.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1984

Headquarters

CEO

SUDHIR JAIRAM VAID

Employees

Contact

Website icon

Website

http://www.concordbiotech.com

Email icon

Email

complianceofficer@concordbiotech.com

Phone icon

Phone

91-079-68138700

Location icon

Location

1482-86 Trasad Road, Dholka, Ahmedabad, Gujarat, 382225

Read More

Concord Biotech Ltd Company History

YearHistory
2018
  • The Company underwent its fifth USFDA inspection and received a 'no action indicated' classification for the facility located at Dholka.
  • The Company received a GMP certification from the Food and Drugs Control Administration for the Valthera and Dholka units.
  • The Company underwent its second USFDA inspection at the Valthera facility and received an establishment inspection report.
  • The Company established a Joint Venture in Japan.
2019
  • The Company received two ANDA approvals.
  • The Company expanded its business in the critical care segment in India.
  • The Company commenced marketing of Mycophenolate Mofetil Capsules USP 250 mg.
2020
  • The Board permitted the layout plan for the proposed injectable manufacturing unit at the Valthera facility.
  • The Company received two ANDA approvals.
  • The Company made its first shipment of Mycophenolate Sodium Tablets to the US market.
2021
  • The Company commenced operations at the second API facility at Limbasi.
  • The Company underwent its third EU GMP inspection of the manufacturing facility located in Dholka.
2023
  • The Company completed the USFDA inspection at the Limbasi facility.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkBuy6169521217.9425 Feb 2026
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkSell6169521218.5825 Feb 2026
UBS PRINCIPAL CAPITAL ASIA LIMITEDbulkSell7401592589.8620 Sept 2024
THE VANGUARD GROUP INC A/C VANGUARD EMERGING MARKETS STOCK INDEX FUND A SERIES OF VANGUARD INTERNATbulkBuy5771832596.0820 Sept 2024
THE VANGUARD GROUP INC A/C VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUNDbulkBuy6979362596.0820 Sept 2024
NORGES BANK ON ACCOUNT OF THE GOVERNMENT PENSION FUND GLOBALbulkBuy6000001386.9528 May 2024
1575773 ONTARIO INCbulkSell35482111361.2628 May 2024
BNP PARIBAS ARBITRAGEblockSell1534211421.725 Jan 2024
SOCIETE GENERALEblockBuy1534211421.725 Jan 2024
GRAVITON RESEARCH CAPITAL LLPbulkBuy735455935.1718 Aug 2023

Read More

Concord Biotech Ltd News

Concord Biotech board to consider bonus issue

Concord Biotech Ltd schedules board meeting for September 23, 2026, to consider a bonus equity share proposal. Trading window remains closed until September 26.

19 Sept 2026

companies

Concord Biotech to host analyst meet on Sep 23

Concord Biotech Limited will hold a group meeting with investors and analysts on September 23, 2026, in Ahmedabad. The event is part of the JP Morgan Healthcare Trip.

17 Sept 2026

companies

Concord Biotech Q1 Results: Net Profit Up 44% YoY

Concord Biotech posts Q1 net profit of 612M rupees vs 425M YoY; revenue rises to 2.6B rupees from 2.04B; EBITDA margin expands to 33.46% from 30.1%.

31 Jul 2026

companies

Concord Biotech Q1FY27 Earnings Call

Concord Biotech Limited schedules earnings call for August 3, 2026, to discuss Q1FY27 standalone and consolidated financial results and business outlook.

28 Jul 2026

companies

Concord Biotech files BRSR for FY26

Concord Biotech filed its Business Responsibility and Sustainability Report for FY26, disclosing ESG metrics and reasonable assurance from auditors.

07 Jul 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Concord Biotech Ltd?

    As of 21/09/2026 at 10:23 PM, Concord Biotech Ltd shares are trading at 1505.70.

  • 2.What is the market cap. of Concord Biotech Ltd?

    As of 21/09/2026, the market capitalization of Concord Biotech Ltd is 15,762.00 crore.

  • 3.When was Concord Biotech Ltd founded?

    Concord Biotech Ltd was founded in 1984.

  • 4.What are the P/E and P/B ratios of Concord Biotech Ltd?

    As of 21/09/2026, Concord Biotech Ltd has a P/E ratio of 57.20 and a P/B ratio of 9.67.

  • 5.How can I buy shares of Concord Biotech Ltd?

    You can buy shares of Concord Biotech Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Concord Biotech Ltd?

    As of March,2026, promoters hold 44.08% in Concord Biotech Ltd, while FIIs, DIIs and public shareholders hold 7.80%, 9.22% and 38.90%, respectively.

  • 7.Does Concord Biotech Ltd pay dividends?

    Yes, Concord Biotech Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was Final Dividend - Rs. - 10.7 per share.

  • 8.What is the dividend yield of Concord Biotech Ltd?

    As of 21 September, 2026, the dividend yield of Concord Biotech Ltd stands at 0.52%.

  • 9.What are the latest financial results of Concord Biotech Ltd?

    For January,2024, Concord Biotech Ltd reported revenue of 1,180.00 crore and a net profit of 372.00 crore.

  • 10.What is the Stock symbol of Concord Biotech Ltd?

    CONCORDBIO is the stock symbol of Concord Biotech Ltd.

  • 11.Who is the CEO of Concord Biotech Ltd?

    The CEO of Concord Biotech Ltd is SUDHIR JAIRAM VAID.

Open Your Free Demat Account

Enter your phone number